Choose language

  • cs

  • de

  • el

  • en

  • es

  • et

  • fr

  • it

  • kk

  • lt

  • nl

  • pl

  • pt

  • ro

  • ru

  • uk

  • Čeština

  • Deutsch

  • ελληνική

  • English

  • Español

  • Eesti keel

  • Français

  • Italiano

  • Казақша

  • Lietuvių

  • Nederlands

  • Polski

  • Português

  • Română

  • Русский

  • Українська

How do you prefer to top up your account?

* We don't charge any commission for making deposits into your account

Vaccitech Plc

IPO has ended 28.04.2021

IPO return for 3 months

-9.24 %

IPO date


Price after Lock up

$ 15.43

IPO price

$ 17.00

End of Lock up


Interested in an IPO? Register and receive information by email.

Financial indicators

Profit m.
Net profit m.
Net debt m.

About Company

Vaccitech, a biotech startup company that contributed to COVID-19 vaccine research, is launching its IPO in the NASDAQ on April 29. All the funds raised with the IPO will be likely invested into drugs against hepatitis B virus, human papilloma virus, and prostate cancer.

Vaccitech took part in developing AstraZeneca vaccine, which is recommended by the World Health Organization.

In March 2020, Vaccitech raised $168M over an investment round, some of the investors being M&G Investment Management, Tencent, Gilead Sciences, Future Planet Capital, and Oxford Sciences Innovation. The officials at the Oxford University are expecting this IPO to be the best start in the scientific R&D domain over the last few years.

Analysts at various investment banks believe the COVID vaccine market may exceed $10 B per year, based on the number of people who take seasonal flu vaccines every year. In case the vaccine gets even more popular, the market size may reach $25B per year.

Vaccitech IPO: Key Facts

● Yield Potential: 35%
● IPO Date: April 29, 2021
● Exchange: NASDAQ (trading as VACC)
● IPO Size: $110,5M
● Starting Price: $16 to $18 per share
● Market Cap: $579M
● Underwriters: Morgan Stanley, Jefferies, Barclays, William Blair
● Earnings, in 2020: $5M
● EBIT, 2020: -$20M
● Net Profit, in 2020: -$18M
● Net Debt, 2020: 0

You can find Vaccitech Security Issue Memo on the SEC website.

You can apply to trade Vaccitech IPO before 7:00 pm UTC+2 on April 28. In order to trade on an IPO, you need an investment account with Freedom Finance. The minimum investment amount is $2,000.

As there is a huge number of people willing to invest into IPO's, you may receive shares worth a smaller amount than you specified in your order. Learn how to increase your allocation and get more IPO shares here.

Please register to buy shares Vaccitech Plc

No fees for the first 30 days from the account opening date!

For EU residents only

  • Commission, per share 0 €
  • Payment by card 0.00 %
Required field
Required field